Current Statements and Work Group Reports Share this page: AAAAI statements are not to be construed as dictating an exclusive course of action; nor are they intended to replace the medical judgment of healthcare professionals. The unique circumstances of individual patients and environments are to be taken into account in any diagnosis and treatment plan. AAAAI statements reflect clinical and scientific advances as of the date of their publication and are subject to change. Listed below are the current statements of the American Academy of Allergy, Asthma & Immunology. These statements are divided into three categories: position statements, systematic reviews, and work group reports. A Work Group Report is a narrative review that provides further comment or clarification on appropriate methods of treatment or care. They are generally created by committees or work groups, and the end goal is to aid practitioners in clinical decision making. They are well referenced and contain an appropriate bibliography. They are not guidelines, but do aid in making decisions for patient care. They do not constitute an official opinion or statement of the AAAAI but serve to bring attention to key clinical or even controversial issues. View the work group report submission and development process. A Position Statement examines an aspect or aspects of clinical practice, research, or public policy pertaining to allergic/immunologic disease, and through literature review and a consensus of experts, sets forth a position designed to outline appropriate care, appropriate application of research, or public policy. They are well referenced and contain an appropriate bibliography. Position Statements are infrequent, and constitute official positions of the AAAAI. A Systematic Review examines an aspect or aspects of clinical practice, research or public policy pertaining to allergic/Immunologic disease in a systematic, reproducible fashion. Most such reviews will address therapies, but proposals focusing on other areas – including diagnosis, prevention, or prognosis – are also encouraged. It is expected that authors will define a question, perform a literature search with specified inclusion and exclusion criteria, abstract and critically appraise data according to methodologic quality and assessment of validity, and transparently describe the overall results of the review and how to apply these results to patient care. These reviews do not constitute official statements or policy of the AAAAI, but do carry the potential for meaningful impact. Surveys The PDT Committee leadership reviews and approves proposals for surveys of and from AAAAI members because these are often linked to the development of Work Group Reports. Members should start by completing the survey request form and be aware of the AAAAI survey data ownership policy. Surveys approved through the PDT Process must be administered through the AAAAI to maintain compliance with the terms of the data ownership policy. Due to the high number of requests received, individual surveys are sent to a 20% randomly selected representative sample of the AAAAI membership. Any group that would only conduct its survey through an external data collection system would be considered an external collaboration, and thus have to be approved by AAAAI leadership as opposed to through PDT. Lifespan of AAAAI Statements After five years from the date of publication, AAAAI position statements and work group reports are not to be considered to reflect current AAAAI standards or policy. The AAAAI maintains these statements in archives for the purpose of reference only. Click here to find out how to proceed with development of a work group report, position statement or systematic review. Current Position Statements and Work Group Reports Allergen Immunotherapy Statement name Published Statement type Allergen Immunotherapy Extract Shortages and Their Effects on Clinical Care: A Work Group Report of the AAAAI Immunotherapy, Allergen Standardization and Allergy Diagnostics Committee November 2021 Work Group Report Applying the dissemination and implementation sciences to allergy and immunology: A Work Group Report from the AAAAI Quality, Adherence, and Outcomes Committee October 2024 Work Group Report Dose Adjustment After Gaps in Administration of Subcutaneous Immunotherapy From a Past Survey: Work Group Report of the AAAAI Allergen Standardization and Allergy Diagnostics Committee January 2023 Work Group Report Guidance for the Evaluation by Payors of Claims Submitted Using Current Procedural Terminology Codes 95165, 95115, and 95117 November 2024 Joint Statement Allergic Disease Statement name Published Statement type AAAAI Position Statement on Changing Electronic Health Record Allergy Documentation to “Alerts” to Lead to Easily Understood, Actionable Labels December 2024 Position Statement Special Article: COVID-19: Pandemic Contingency Planning for the Allergy and Immunology Clinic March 2020 Special Article Allergy Electronic Health Record Documentation: A 2022 Work Group Report of the AAAAI Adverse Reactions to Drugs, Biologicals, and Latex Committee September 2022 Work group report Allergy/Immunology Trainee Experiences During the COVID-19 Pandemic: AAAAI Work Group Report of the Fellows-in-Training Committee October 2020 Work Group Report Electronic Cigarettes and Their Impact on Allergic Respiratory Diseases: A Work Group Report of the AAAAI Environmental Exposures and Respiratory Health Committee March 2021 Work Group Report Environmental justice and allergic disease: A Work Group Report of the AAAAI Environmental Exposure and Respiratory Health Committee and the Diversity, Equity and Inclusion Committee January 2023 Work Group Report Factors Influencing Career Choice of Allergy and Immunology Fellows-in-Training: A Work Group Report of the AAAAI Program Directors Assembly Executive Committee March 2024 Work Group Report Nasal allergen challenge (NAC): Practical aspects and applications from an EU/US perspective—a Work Group Report of the AAAAI Rhinitis, Rhinosinusitis and Ocular Allergy Committee May 2023 Work Group Report The Impact of Prior Authorization on Clinical Practice and Patient Care Outcomes: A Work Group Report of the AAAAI Prior Authorization Task Force July 2024 Work Group Report The Impact of Prior Authorization in Allergy/Immunology: A Position Statement of the American Academy of Allergy, Asthma & Immunology. February 2023 Position Statement Anaphylaxis Statement name Published Statement type The Need for Required Stock Epinephrine in All Schools: A Work Group Report of the AAAAI Adverse Reactions to Foods Committee April 2023 Work Group Report Asthma Statement name Published Statement type Ensuring equitable access to guideline-based asthma care across the lifespan: Tips and future directions to the successful implementation of the new NAEPP 2020 guidelines, a Work Group Report of the AAAAI Asthma, Cough, Diagnosis, and Treatment Committee April 2023 Work Group Report Evolving concepts in how viruses impact asthma: A Work Group Report of the Microbes in Allergy Committee of the American Academy of Allergy, Asthma & Immunology May 2020 Work Group Report Perspectives in Diagnosis and Management of Exercise-Induced Bronchoconstriction in Athletes September 2020 Work Group Report Pulmonary Procedures During the COVID-19 Pandemic: A Workgroup Report of the American Academy of Allergy, Asthma & Immunology (AAAAI) Asthma Diagnosis and Treatment (ADT) Interest Section April 2022 Work Group Report Recommendations for Physical Activity in Asthma: A Work Group Report of the AAAAI Sports, Exercise, and Fitness Committee February 2022 Work Group Report Results From a National Survey of Asthma Provider Beliefs and Practices Regarding Exercise and Asthma: A Work Group Report of the AAAAI Committee on Sports, Exercise, and Fitness June 2022 Work Group Report Drug Allergy Statement name Published Statement type Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: Specific Drugs October 2020 Work Group Report Penicillin Allergy Evaluation Should Be Performed Proactively in Patients with a Penicillin Allergy Label – A Position Statement of the American Academy of Allergy, Asthma & Immunology August 2023 Position Statement The Role of Aspirin Desensitization Followed by Oral Aspirin Therapy in Managing Patients with Aspirin-Exacerbated Respiratory Disease: A Work Group Report from the Rhinitis, Rhinosinusitis and Ocular Allergy Committee of the American Academy of Allergy, Asthma & Immunology March 2021 Work Group Report Food Allergy Statement name Published Statement type Addressing health disparities in food allergy: A Position Statement of the AAAAI Prior Authorization Task Force January 2025 Position Statement An International Delphi Consensus on the Management of Pollen-Food Allergy Syndrome: A Work Group Report of the AAAAI Adverse Reactions to Foods Committee December 2024 Work Group Report Atopic Dermatitis and Food Allergy: Best Practices and Knowledge Gaps—A Work Group Report from the AAAAI Allergic Skin Diseases Committee and Leadership Institute Project March 2022 Work Group Report Baked Milk and Baked Egg Survey: A Work Group Report of the AAAAI Adverse Reactions to Foods Committee August 2023 Work Group Report Conducting an Oral Food Challenge: An Update to the 2009 Adverse Reactions to Foods Committee January 2020 Work Group Report Food Allergy in Restaurants January 2020 Work Group Report Food Allergy Management Practices Utilizing Individual Patient Thresholds: A Work Group Report of the AAAAI Adverse Reactions to Foods Committee April 2023 Work Group Report Food Insecurity in the Food Allergic Population: A Work Group Report of the AAAAI Adverse Reactions to Foods Committee January 2022 Work Group Report Food Oral Immunotherapy: A Survey Among US Practicing Allergists Conducted as a AAAAI Leadership Institute Project and Work Group Report August 2023 Work Group Report Oral Food Challenge for FPIES in Practice—A Survey: Report from the Work Group on FPIES Within the Adverse Reactions to Foods Committee, FAED IS, AAAAI October 2021 Work Group Report AAAAI Work Group Report: Trends in Oral Food Challenge Practices Among Allergists in the United States November 2020 Work Group Report The Development of Age-Based Food Allergy Educational Handouts for Caregivers and Patients: A Work Group Report of the AAAAI Adverse Reactions to Foods Committee Access the handouts. October 2022 Work Group Report The use and implementation of omalizumab as food allergy treatment: Consensus-based guidance and Work Group Report of the Adverse Reactions to Foods Committee of the American Academy of Allergy, Asthma & Immunology January 2025 Work Group Report Health Disparities Statement name Published Statement type Food Insecurity in the Food Allergic Population: A Work Group Report of the AAAAI Adverse Reactions to Foods Committee January 2022 Work Group Report Health Disparities in Allergic and Immunologic Conditions in Racial and Ethnic Underserved Populations: A Work Group Report of the AAAAI Committee on the Underserved May 2021 Work Group Report Volunteerism Addressing Environmental Disparities in Allergy (VAEDIA): The presidential initiative to combat environmental injustice in allergy and immunology—a Work Group Report of the AAAAI VAEDIA task force July 2024 Work Group Report Mast Cell Disorders Statement name Published Statement type Developing a standardized approach for assessing mast cells and eosinophils on tissue biopsies: A Work Group Report of the AAAAI Allergic Skin Diseases Committee August 2021 Work Group Report Primary Immunodeficiency Statement name Published Statement type Diagnostic interpretation of genetic studies in patients with primary immunodeficiency diseases: Aworking group report of the Primary Immunodeficiency Diseases Committee of the American Academy of Allergy, Asthma & Immunology January 2020 Work Group Report Practical guidance for the diagnosis and management of secondary hypogammaglobulinemia: A Work Group Report of the AAAAI Primary Immunodeficiency and Altered Immune Response Committee March 2022 Work Group Report Telemedicine Statement name Published Statement type COVID-19: Unmasking Telemedicine July 2020 Work Group Report Technology Statement name Published Statement type A Framework for Augmented Intelligence in Allergy and Immunology Practice and Research—A Work Group Report of the AAAAI Health Informatics, Technology and Education Committee March 2022 Work Group Report Wellness Statement name Published Statement type Fellows in Training Wellness in Allergy and Immunology: AAAAI Workgroup Report October 2022 Work Group Report Physician Wellness in Allergy and Immunology April 2020 Work Group Report Share this page: